CTOs on the Move

Prematics

www.prematics.com

 
Prematics, Inc is a Mclean, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.prematics.com
  • 8484 Westpark Dr Ste 150
    Mclean, VA USA 22102
  • Phone: 703.956.5500

Executives

Name Title Contact Details

Similar Companies

Columbus Regional Healthcare System

Columbus Regional Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Columbus Regional Healthcare System is based in Whiteville, NC. You can find more information on Columbus Regional Healthcare System at www.crhealthcare.org

Exeter House

Exeter House is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kindbridge Behavioral Health

Kindbridge Behavioral Health is a company that provides online mental health services across the USA with a focus on gambling and gaming disorder treatment and therapy.

Embodied,

Moxie is a revolutionary new animate companion for children designed to help promote social, emotional and cognitive development through play-based learning.

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.